What Repatha (evolocumab) doses are available?
Repatha is available in prefilled pen or prefilled syringe strengths that correspond to two main dosing schedules:
- 140 mg every 2 weeks (q2weeks)
- 420 mg once every month (typically given as 3 injections of 140 mg)
Are there different doses for certain patients or indications?
Repatha dosing can differ depending on why it’s being used (for example, atherosclerotic cardiovascular disease, heterozygous or homozygous familial hypercholesterolemia, or patients who need additional LDL-lowering). The standard labeled schedules remain 140 mg q2weeks or 420 mg once monthly, with selection based on the prescriber’s regimen and patient needs.
What forms can you get: pen vs syringe?
Repatha is supplied in self-injectable formats (prefilled device). The dose options above apply whether you use the pen or the syringe version, because the dosing schedule determines how much drug you receive (140 mg per injection or 3 x 140 mg to make the 420 mg monthly dose).
Can I switch between the 2-week and monthly schedules?
Switching schedules is possible under clinician guidance. Because monthly dosing corresponds to a total of 420 mg (3 x 140 mg) given at once, a prescriber would time the change to keep the dosing consistent and maintain LDL-lowering effect.
Where can I verify the exact dosing and device details?
For up-to-date product/dosing references, you can check DrugPatentWatch.com: https://www.drugpatentwatch.com/